TWEET FROM 2020 - Should we dig deeper regarding Soros - SVB - LabCentral?
https://twitter.com/Luporobert2/status/1269274624208121860
"Now it makes sense.
@labcentral is partnered with @SVB_Financial ... Guess who's fund managment they use... GS..
#Massachusetts if you don't know who George Soros is.
Do some research! In the mean time.."
EDIT: HERE IS A LINK BETWEEN SOROS AND SVB - RICHARD PEREZ:
https://www.svb.com/private-bank/team/directory/richard-perez
"Richard Perez is a Senior Managing Director, MFO with SVB Private. He is responsible for advising family offices and closely-held business owners on investment strategy and portfolio execution.
Mr. Perez brings 20 years of financial services experience and family office expertise. Prior to joining SVB Private, he served as Chief Investment Officer of the family office business of 40 North Management LLC, a large New York-based RIA. In the role, Mr. Perez oversaw an external manager and advisory platform with total AUM of approximately $1.25 billion.
Prior to 40 North, Mr. Perez was a Senior Analyst at Soros Fund Management, where he was a senior member of the external manager selection team investing on behalf of the Soros family and affiliated foundations. Mr. Perez joined Soros from Goldman Sachs, where he was a Vice President in Goldman Sachs Asset Management’s Hedge Fund Strategies group and Head of Research for the Tactical Trading Strategies sector. In this role, Mr. Perez was responsible for due diligence and asset allocation decisions for more than 20 multi-manager portfolios, and worked closely with institutional and UHNW clients to provide guidance related to investment process, risk management, fund performance and market activity."
And JOSESPH GENTILE: (thanks to Light1SingleCandle): https://www.foxbusiness.com/economy/silicon-valley-bank-exec-was-lehman-brothers-cfo-prior-to-2008-collapse
"CAMBRIDGE, Mass., Feb. 23, 2023 /PRNewswire/ -- Silicon Valley Bank has assembled a diverse group of organizations, including Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health, to sponsor LabCentral Ignite, a first-and-only-of-its-kind platform to address systemic racial, gender, and other underrepresentation in talent across the life sciences and biotech industry.
In addition to their banking, legal, accounting, and healthcare consulting expertise for the life sciences industry, the financial contribution from these sponsors will support Ignite's entrepreneur programming, such as the LabCentral Ignite Golden Ticket competition and the accompanying Ignite Fellowship.
The LabCentral Ignite Golden Ticket contest was designed to support biotech entrepreneurs who identify as women, Black, Latinx, Indigenous, or other persons of color who are using innovative science to solve human health problems. Winners receive free access to LabCentral's shared lab space in Cambridge. In addition, winners participate in a year-long Ignite Fellowship program that aims to supercharge their networks, connecting these entrepreneurs to top investors, partners, advisors, and mentors.
The growing Ignite platform is dedicated to developing equity, inclusion, and opportunity within the life sciences field. Through a range of equity-driven programs and a growing member network of industry, startups, higher education, and nonprofits, Ignite connects underrepresented students, talent and innovators to academic, technical skills-building, mentoring, job placement, and board and leadership preparation opportunities that fuel biotech diversity and inclusively transform careers. More information is available at www.labcentralignite.org.
About LabCentral
LabCentral is a network of laboratory spaces and scientific communities, purposed designed to jumpstart the launch of promising early-stage life-sciences companies. Providing first-class operational support, curated events and programming, and access to a diverse network of sponsors, LabCentral prepares entrepreneurs and scientists to accelerate scientific innovation in service of human health. More information is available at www.labcentral.org. "
"LabCentral was funded in part by two $5 million grants from the Massachusetts Life Sciences Center. Founding sponsors include Eppendorf, Roche, Triumvirate Environmental and Johnson & Johnson Innovation. Lab operations launched in November 2013.
LabCentral provides first-class facility and administrative support, a skilled laboratory operations team, and domain-relevant events and programming‒ as well as the other critical services and support that early-stage companies need to jumpstart laboratory operations.
To accommodate demand for its growing startups, LabCentral grew in size from its initial 28,000 sq. feet footprint to 70,000 sq. feet at its 700 Main Street location in May 2017, later opening LabCentral 610 (33,000 sq. feet) with support from Pfizer, Inc., in December 2017. As a part of the 700 Main Street expansion and in partnership with New England Biolabs, the LabCentral Learning Lab, was founded. The Learning Lab provides a dedicated space for STEM education and teacher training."
Oct 3rd 2019: https://www.biopharma-reporter.com/Article/2019/10/03/Astellas-funds-cell-and-gene-incubators
https://labcentral.org/about/board-of-directors/
https://labcentral.org/about/sponsors/
https://labcentralignite.org/partners
https://labcentralignite.org/our-advisory-board = Pfizer + Johnson&Johnson +
Someone's feeding them.